Editor’s Note: The home page of the BioNJ website provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in the News section are encouraged to email their news releases to BioNJ.
April 12
Pacira Pharmaceuticals, Inc. Prices Public Offering of Common Stock
CircuLite to Provide New Information on Synergy in Three Presentations at ISHLT Annual Meeting
Advaxis Awarded Best Therapeutic Vaccine
April 11
Proteonomix Announces Termination of Contract with the University of Miami
April 10
Advaxis Announces Presentations at World Vaccine Congress 2012
April 9
Proteonomix Updates Progress on Multiple Programs
April 5
Advaxis Announces Collaboration with the Karolinska Institutet
April 4
Personalized Medicine and Combination Potential of Cyclacel’s Sapacitabine Highlighted at AACR
BASF and Catalent Join Forces to Solve Bioavailability Challenges
Laureate Biopharma Names James D. Utterback to Board of Directors
Immunomedics Develops Novel Agents Targeting Renal Cell Carcinoma
April 2
VaxInnate Names Wayne Pisano as Its New CEO
Unigene Appoints Jack Wyszomierski to Its Board of Directors
Immunomedics Reports Clinical Results of Pretargeted Radioimmunotherapy of Colorectal Cancer
Cyclacel’s Novel Polo-Like Kinase 1 (Plk1) Inhibitors Highlighted at AACR
Immunomedics Develops Bispecific Hexavalent Antibodies for Diverse Epithelial Cancers
Bristol-Myers Squibb to Announce Results for First Quarter 2012 on April 26
March 30
QPharma Executive Promoted to Chief Information Officer
March 29
Oticon, Inc. Introduces Invisible Hearing Device for People Who Want the Ultimate in Discretion
March 28
Antares Pharma to Present at the 11th Annual Needham Healthcare Conference
Advaxis Announces Abstracts Accepted for Poster Presentation at AACR Annual Meeting 2012
Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer
Merck Provides Update on IMPROVE-IT Trial
Proteonomix, Inc. Updates Progress of Proteoderm Subsidiary
Aegerion Pharmaceuticals to Present at the Needham Healthcare Conference
Merck to Hold First-Quarter 2012 Sales and Earnings Conference Call on April 27
Laureate Biopharma Appoints Lisa Cozza as Vice President, Business Development
NPS Pharmaceuticals to Present at Needham Healthcare Conference
Lexicon Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference
March 26
Immunomedics to Report Progress with Novel DNL Agents Targeting Solid Tumors at Cancer Conference
Supreme Court Denies Apotex’s Petition for a Writ of Certiorari
SAFE-BioPharma Named Computerworld Laureate for IT Use Benefiting Society
NovaDel Reports Unaudited Financial Results for Fourth Quarter and Year Ended December 31, 2011